DRKS00032601招募中不适用
Discovery of antigen and antibody profiles in response to yellow fever vaccination as a model for an infection
Abteilung für Infektions- und Tropenmedizin, LMU Klinikum0 个研究点目标入组 120 人开始时间: 2023年10月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Eligible for Yellow fever vaccine due to travel or other reasons
- •- Available for majority of time points
排除标准
- •- Allergies or known sensitivity to yellow fever vaccine or components of the vaccine
- •- Vaccination against Japanese encephalitis, FSME or Dengue 4 weeks prior or after the yellow fever vaccination
- •- known positivity for acute/active blood borne diseases such as HIV, HepC or HepB
- •-known condition leading to immuno-suppression e.g. solid cancer, known haematological abnormities
- •- immuno-suppressive drugs such as systemic steroids, chemotherapy, immunosuppressive treatment of
- •rheumatoid arthritis
- •- other known exclusion criteria for yellow fever vaccine
研究者
相似试验
已完成
不适用
immunogenicity of pneumococcal vaccine in children with systemic lupus erythematosussystemic lupus erythematosus (SLE).Systemic lupus erythematosusIRCT138811293361N1Shiraz University of Medical Science60
招募中
不适用
Detection and evaluation of antibody formation against biologics in psoriasispsoriasis1000381610014982NL-OMON35618Academisch Medisch Centrum240
进行中（未招募）
1 期
Analysis and characterization of the immune response after influenza, SARS-CoV-2 and pneumococcal vaccinations (IMMUNE Study)Analysis and characterization of the immune response after influenza, SARS-CoV-2 and pneumococcal vaccinations (IMMUNE Study)EUCTR2021-002789-42-ATMedizinische Universität Innsbruck1,000
招募中
不适用
Molecular immunological characterisation and multi-centric patient-centered care of children and adolescents with Long COVID in Baden-WürttembergG93.3Postviral fatigue syndromeDRKS00033269niversitätsklinikum Freiburg, Zentrum für Kinder- und Jugendmedizin200
招募中
不适用
Discovering immune complex antigen specific for oral cancer in salivaoral cancerJPRN-UMIN000035607agasaki University210